Revelation Biosciences (REVB) Stock Soars 90% After Reporting Trial Results

InvestorPlace - Stock Market News, Stock Advice & Trading Tips

Revelations Biosciences (REVB) stock is jumping 90% after the company reported the results of a study of its hay fever treatment. 

The post Revelation Biosciences (REVB) Stock Soars 90% After Reporting Trial Results appeared first on InvestorPlace.

• Buy This $5 Stock BEFORE This Apple Project Goes Live
• The Best $1 Investment You Can Make Today
• Early Bitcoin Millionaire Reveals His Next Big Crypto Trade “On Air”
• Cash Holders Could Get Hit Hard THIS FRIDAY